Hey everybody, happy April!! April is one of the best months of the year. The rain is the best and worst part in my opinion. I hope you all are enjoying Spring so far.
In today’s blog, we’ll be talking about a new medicinal drug known as Ocrevus. Ocrevus was approved March 28th by the FDA to treat adults who have Multiple Sclerosis relapses, or Primary Progressive Multiple Sclerosis. It is the first of its kind to be approved by the FDA. It is an intravenous infusion given to a patient by his/her doctor. Billy Dunn, Director of the Division of Neurology Products says, “Multiple Sclerosis can have a profound impact on a person’s life. This therapy not only provides another treatment option for those with relapsing MS but for the first time provides an approved therapy for those with primary progressive MS.“
For those of you that don’t know Multiple Sclerosis is a chronic, inflammatory, autoimmune disease of the central nervous system that disrupts communication between the brain and other parts of the body. It is among the most common causes of neurological disability in young adults and occurs more frequently in women than men. A person with MS can get symptoms as young as 20, and as old as 40. Primary Progressive Multiple Sclerosis is different because it steadily gets worse with no periods of remission or relapse. The CDC estimates that 15% of people with MS has PPMS as well. The trial results of Ocrevus for treating an MS relapse reduced relapse rates and the worsening of the disability compared to Rebif another popular brand. Ocrevus for treating Primary Progressive Multiple Sclerosis also showed reduced worsening of the disability. For more on the drug check out the article here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549325.htm
So what do you all think? Can this new drug really help MS patients?